Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...

A cancer 'vaccine' developed by a Yale University scientist kept people's kidney cancer from recurring for three years, ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for ...

Recent findings from the Prostate Health Education Network (PHEN) study and how Black men can take next steps for their ...

Findings support the development of a novel peptide vaccine targeting the immunosuppressive effects of Transforming Growth Beta (TGF-β) in ...

Cancer deaths among Black men and women in the United States have declined during the past decade in the United States, a new American Cancer Society report says.

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...

A cancer vaccine will be available to women within a few months in India, Union Minister of State for Health, Family Welfare ...

Thousands of men are to be checked for prostate cancer in one of the first large-scale European trials of smart screening.